Immune Tolerance Network   A clinical research consortium sponsored by NIAID and JDRF
START logoA clinical research study of thymoglobulin to arrest type 1 diabetes

   
  learning
  the trial
  participating
START | contactsselected

 

Contact Us

Recruitment for the START study is now closed.

For information on additional ITN trials for people recently diagnosed with type 1 diabetes, please visit:

Retain Study
www.retainstudy.org

T1DAL Study
www.t1dal.org
spacer
spacer
 
Terms of Use | Privacy | Accessibility
©2007, Immune Tolerance Network
spacer